Anaphylaxis and Infusion site extravasation

Summary:

Infusion site extravasation is found among people with Anaphylaxis, especially for people who are female, 60+ old.

The study analyzes which people have Infusion site extravasation with Anaphylaxis. It is created by eHealthMe based on reports of 15 people who have Anaphylaxis from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.

What is Anaphylaxis?

Anaphylaxis (serious allergic reaction that is rapid in onset and may cause death) is found to be associated with 1,935 drugs and 2,859 conditions by eHealthMe. Check the latest studies of Anaphylaxis.

What is Infusion site extravasation?

Infusion site extravasation (flow of (blood or lymph) from infusion site) is found to be associated with 649 drugs and 590 conditions by eHealthMe. Check the latest studies of Infusion site extravasation.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 22, 2026

15 people who have Anaphylaxis and Infusion Site Extravasation are studied.

Would you have Infusion site extravasation when you have Anaphylaxis?

Gender of people who have Anaphylaxis and experienced Infusion Site Extravasation *:

female: 60 %
male: 40 %

Age of people who have Anaphylaxis and experienced Infusion Site Extravasation *:

Common co-existing conditions for these people *:

Immunodeficiency Common Variable: 3 people, 20.00%
Fabry's Disease (build up of a particular type of fat, called globotriaosylceramide, in the body's cells): 3 people, 20.00%
Hypogammaglobulinaemia (an abnormally low concentration of gamma globulin in the blood and increased risk of infection): 2 people, 13.33%
Skin Blushing/flushing (a sudden reddening of the face, neck): 1 person, 6.67%
Autonomic Neuropathy (malfunction of the autonomic nervous system (ans)): 1 person, 6.67%
Asthma: 1 person, 6.67%
Acute Severe Asthma: 1 person, 6.67%

Common drugs taken by these people *:

Common symptoms for these people *:

Infusion Site Erythema (reddening of the skin at infusion site): 3 people, 20.00%
Peripheral Swelling: 2 people, 13.33%
Arrhythmias (irregular heartbeat): 2 people, 13.33%
Infusion Site Swelling: 2 people, 13.33%
Infusion Related Reaction: 1 person, 6.67%
Adverse Event: 1 person, 6.67%
Chills (felling of cold): 1 person, 6.67%
Fatigue (feeling of tiredness): 1 person, 6.67%
Heart Rate Irregular: 1 person, 6.67%
Influenza Like Illness: 1 person, 6.67%

* Approximation only. Some reports may have incomplete information.

Do you take medications and have Infusion site extravasation?

- Check whether Infusion site extravasation is associated with a drug or a condition

Related publications that referenced our studies

An?eli? N, Erdeljan S, Popovi? R, Bo?i? T, "Anaphylaxis on graft reperfusion during orthotopic liver transplantation: A case study", Srpski arhiv za celokupno lekarstvo, 2016 Jan .
Thangakunam B, Christopher DJ, Mathews V, Srivastava A, "Mesenchymal stromal stem cell therapy in advanced interstitial lung disease-Anaphylaxis and short-term follow-up", Lung India: official organ of Indian Chest Society, 2015 Jan .
Guensley Delva, M. D., & Muse, I, "Rare case of laryngeal edema and anaphylaxis to Ofirmev (IV Acetaminophen): Case Report", , 2012 Jan .
Azkur D, Yoldas T, Toyran M, Kocabas CN, "A pediatric case of anaphylaxis due to octreotide", Asian Pacific journal of allergy and immunology, 2011 Dec .
An?eli? N, Erdeljan S, Popovi? R, Bo?i? T, "Anaphylaxis on graft reperfusion during orthotopic liver transplantation: A case study", Srpski arhiv za celokupno lekarstvo, 2016 Jan .
Thangakunam B, Christopher DJ, Mathews V, Srivastava A, "Mesenchymal stromal stem cell therapy in advanced interstitial lung disease-Anaphylaxis and short-term follow-up", Lung India: official organ of Indian Chest Society, 2015 Jan .
Guensley Delva, M. D., & Muse, I, "Rare case of laryngeal edema and anaphylaxis to Ofirmev (IV Acetaminophen): Case Report", , 2012 Jan .
Azkur D, Yoldas T, Toyran M, Kocabas CN, "A pediatric case of anaphylaxis due to octreotide", Asian Pacific journal of allergy and immunology, 2011 Dec .

Related studies:

How the study uses the data?

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

The study is based on Infusion site extravasation and Anaphylaxis, and their synonyms.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.